Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Successful Management of Intracranial Hemorrhage with Emicizumab in a Newborn with Severe Hemophilia a: A Case Report

Matteo Luciani, Sr., Sonia Iavarone, Sr., Angelo Claudio Molinari, Francesca Campi, Sr., Sara Ronci, Sr., Andrea Dotta, Giovina Di Felice

Blood (2023) 142 (Supplement 1): 5508.

https://doi.org/10.1182/blood-2023-186535

Published: 2023

Journal Articles

In Vitro Analysis of Bone Remodeling Alterations in Hemophilia: Influence of Coagulation Factors on Bone Cells

Stefano Lancellotti, Giulia Battafarano, Monica Sacco, Maira Tardugno, Leonardo Di Gennaro, Matteo Luciani, Raimondo De Cristofaro, Andrea Del Fattore

Blood (2023) 142 (Supplement 1): 2605.

https://doi.org/10.1182/blood-2023-182702

Published: 2023

Journal Articles

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Jacqueline Halton, MD, Leonardo R. Brandao, MD, Matteo Luciani, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Ildar Nurmeev, MD, Anjali Sharathkumar, MD, Pavel Svirin, MD, Kirill Gorbatikov, MD, Igor Tartakovsky, MD, Monika Simetzberger, DI, Fenglei Huang, PhD, Zhichao Sun, PhD, Jörg Kreuzer, MD, Savion Gropper, MD, Martina Brueckmann, MD, Manuela Albisetti, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136682

Published: 2020

Journal Articles

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Leonardo R. Brandao, MD, Igor Tartakovsky, MD, Manuela Albisetti, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Matteo Luciani, MD, Paola Saracco, MD, Judy Felgenhauer, MD, Olga Lvova, MD, Monika Simetzberger, DI, Zhichao Sun, PhD, Ingrid Gergei, MD, Martina Brueckmann, MD, Jacqueline Halton, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136695

Published: 2020

Journal Articles

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Leonardo R. Brandão, Manuela Albisetti, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Lesley G. Mitchell, Ildar Nurmeev, Pavel Svirin, Tomas Kuhn, Ondrej Zapletal, Igor Tartakovsky, Monika Simetzberger, Fenglei Huang, Zhichao Sun, Jörg Kreuzer, Savion Gropper, Martina Brueckmann, Matteo Luciani

Blood (2020) 135 (7): 491–504.

https://doi.org/10.1182/blood.2019000998

Published: 2020

Includes: Supplemental data

Journal Articles

Rationale and Design of a Phase III Single-Arm Multicenter Study of Dabigatran Etexilate for the Secondary Prevention of Venous Thromboembolism in Children

Matteo Luciani, Manuela Albisetti, MD, Ivan Manastirski, Martina Brueckmann, MD, Savion Gropper, MD, Igor Tartakovsky, MD, Bushi Wang, Branislav Biss, Lesley G Mitchell, Fenglei Huang, Jacqueline ML Halton, MD, Leonardo R. Brandão, MD MSc

Blood (2016) 128 (22): 5028.

https://doi.org/10.1182/blood.V128.22.5028.5028

Published: 2016

Journal Articles

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-<2 and 2-<12 Years Old), with Venous Thromboembolism

Jacqueline ML Halton, MD, Manuela Albisetti, MD, Matteo Luciani, Fenglei Huang, Branislav Biss, Martina Brueckmann, MD, Savion Gropper, MD, Hugo Maas, Igor Tartakovsky, MD, Lesley G Mitchell

Blood (2016) 128 (22): 87.

https://doi.org/10.1182/blood.V128.22.87.87

Published: 2016

Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

C. Michel Zwaan, MD PhD, Stefan Söderhäll, MD PhD, Benoit Brethon, MD, Matteo Luciani, MD, Carmelo Rizzari, MD, David Sternberg, MD PhD, Emmanuelle Besse, Catherine Dutreix, MD, Franca Fagioli, MD, Phoenix Ho, MD, Carlo Dufour, MD, Rob Pieters, MD PhD

Blood (2015) 126 (23): 2564.

https://doi.org/10.1182/blood.V126.23.2564.2564

Published: 2015

Journal Articles

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2013) 122 (2): 170–178.

https://doi.org/10.1182/blood-2013-03-491621

Published: 2013

Journal Articles

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Riccardo Masetti, MD, Martina Pigazzi, PhD, Andrea Pession, Prof, MD, Carmelo Rizzari, MD, PhD, Nicola Santoro, Luca lo Nigro, Matteo Luciani, Giuseppe Menna, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2012) 120 (21): 3585.

https://doi.org/10.1182/blood.V120.21.3585.3585

Published: 2012

Journal Articles

Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study

Davide Matino, Alfonso Iorio, Marco Gargaro, Giuseppe Tagariello, Matteo Luciani, Giovanni Di Minno, Antonio Coppola, Leonardo Di Gennaro, Paolo Puccetti, Francesca Fallarino

Blood (2011) 118 (21): 26.

https://doi.org/10.1182/blood.V118.21.26.26

Published: 2011

Journal Articles

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Andrea Pession, C. Rizzari, Maria Caterina Putti, Riccardo Masetti, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Nicola Santoro, Anna Maria Testi, Roberto Rondelli, Andrea Biondi, Giuseppe Basso, Franco Locatelli

Blood (2009) 114 (22): 17.

https://doi.org/10.1182/blood.V114.22.17.17

Published: 2009

Journal Articles

Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006).

Blood (2009) 114 (22): 1578.

https://doi.org/10.1182/blood.V114.22.1578.1578

Published: 2009

Journal Articles

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Giovanni Cazzaniga, Riccardo Masetti, Giulia Ferrari, Tiziana Coliva, Carmelo Rizzari, Roberto Rondelli, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Maria Caterina Putti, Nicola Santoro, Giuseppe Basso, Franco Locatelli, Andrea Biondi, Andrea Pession

Blood (2009) 114 (22): 2643.

https://doi.org/10.1182/blood.V114.22.2643.2643

Published: 2009

Journal Articles

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Concetta Micalizzi, MD, Rosanna Parasole, Maria Caterina Putti, MD, Matteo Luciani, MD, Laura Banov, MD, Fara Petruzziello, Chiara Messina, Giulio De Rossi

Blood (2008) 112 (11): 3953.

https://doi.org/10.1182/blood.V112.11.3953.3953

Published: 2008

Journal Articles

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Matteo Luciani, MD, Valeria Pansini, MD, Valentina Coletti, MD, Daria Funaro, MD, Massimiliano Soldati, MD, Simona Pancotti, Piergiorgio Falappa, MD, Giulio De Rossi, MD

Blood (2008) 112 (11): 5357.

https://doi.org/10.1182/blood.V112.11.5357.5357

Published: 2008

Journal Articles

Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy.

Maurizio Arico, Maria Grazia Valsecchi, Carmelo Rizzari, Elena Barisone, Andrea Biondi, Fiorina Casale, Franco Locatelli, Luca Lo Nigro, Matteo Luciani, Chiara Messina, Concetta Micalizzi, Rosanna Parasole, Andrea Pession, Nicola Santoro, Anna Maria Testi, Daniela Silvestri, Giuseppe Basso, Giuseppe Masera, Valentino Conter

Blood (2007) 110 (11): 1440.

https://doi.org/10.1182/blood.V110.11.1440.1440

Published: 2007

Journal Articles

TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Blood (2007) 110 (11): 848.

https://doi.org/10.1182/blood.V110.11.848.848

Published: 2007

Journal Articles

Acute Lymphoblastic Leukemia in Children with Associated Genetic Conditions Other Than Down Syndrome. The AIEOP Experience.

Ottavio Ziino, Roberto Rondelli, Fulvio Porta, Rossella Mura, Concetta Micalizzi, Valentino Conter, Marie France Pinta Boccalatte, Chiara Messina, Matteo Luciani, Elena Barisone, Franco Locatelli, Andrea Pession, Giuseppe Basso, Andrea Biondi, Giuseppe Masera, Maurizio Aricò

Blood (2005) 106 (11): 863.

https://doi.org/10.1182/blood.V106.11.863.863

Published: 2005

Journal Articles

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Elena Santagostino, MD, PhD, Angiola Rocino, MD, Maria E. Mancuso, MD, Maria G. Mazzucconi, MD, Giacomo Mancuso, MD, Maria Messina, MD, Annarita Tagliaferri, MD, Matteo Luciani, MD, Elio Boeri, MD, Pier M. Mannucci, MD

Blood (2004) 104 (11): 37.

https://doi.org/10.1182/blood.V104.11.37.37

Published: 2004

NARROW

Successful Management of Intracranial Hemorrhage with Emicizumab in a Newborn with Severe Hemophilia a: A Case Report

In Vitro Analysis of Bone Remodeling Alterations in Hemophilia: Influence of Coagulation Factors on Bone Cells

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Rationale and Design of a Phase III Single-Arm Multicenter Study of Dabigatran Etexilate for the Secondary Prevention of Venous Thromboembolism in Children

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-<2 and 2-<12 Years Old), with Venous Thromboembolism

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006).

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy.

TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Acute Lymphoblastic Leukemia in Children with Associated Genetic Conditions Other Than Down Syndrome. The AIEOP Experience.

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only